I don't think you should beat yourself up too much over your decision to enter. There were many positive signs at that stage:
- Much positive research around Mente.
- A wealth of positive testimonial from informal in-home trials.
- Distribution agreements in place around the world.
- A clinical trial in progress, which had reported astonishingly strong interim results.
- Plans to use the clinical trial results in an application to the FDA.
- Plenty of cash on hand to finish the trial and lodge the FDA submission.
I felt that was more than enough to justify an investment.
But items 3 to 6 have all evaporated. Most shockingly was the degree to which the clinical trial results evaporated from "some subjects performing in the normal range" hype to a set of barely significant changes for a small set of target tests. That destroyed the prospects of getting FDA clearance. That in turn destroyed the chances of getting any kind of subsidies for the product as a therapeutic device. As a consequence the company's marketing strategy was left in tatters, requiring a complete strategic rethink.
Add in the bolts out of the blue – employee legal action and fake academic qualifications – that have left the device's and company's reputations in tatters, and the investment picture today is completely different. In my view, this stock is not to be touched with a barge-pole.
I sold at a 50% loss last year when the company's update mentioned a "long, expensive but well-tested road" ahead. That statement had "hopeless" written all over it!
Good luck to you if you choose to stay in, but I think that this stock comprehensively fails the "should I stick with it" test.
- Forums
- ASX - By Stock
- NTI
- cash position
cash position, page-4
-
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
|
|||||
Last
7.8¢ |
Change
0.001(1.30%) |
Mkt cap ! $79.35M |
Open | High | Low | Value | Volume |
7.8¢ | 7.8¢ | 7.7¢ | $6.518K | 83.82K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 118119 | 7.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.9¢ | 85471 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 118119 | 0.078 |
2 | 450505 | 0.077 |
4 | 161465 | 0.076 |
3 | 263338 | 0.075 |
1 | 160000 | 0.074 |
Price($) | Vol. | No. |
---|---|---|
0.079 | 85471 | 2 |
0.080 | 94270 | 2 |
0.081 | 30709 | 2 |
0.082 | 85000 | 1 |
0.086 | 100000 | 2 |
Last trade - 11.27am 23/07/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online